ConvaTec Group Plc (CNVVY)
CNVVY Stock Price Chart
Explore ConvaTec Group Plc interactive price chart. Choose custom timeframes to analyze CNVVY price movements and trends.
CNVVY Company Profile
Discover essential business fundamentals and corporate details for ConvaTec Group Plc (CNVVY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
26 Jan 2017
Employees
10.49K
Website
https://www.convatecgroup.comCEO
Karim Bitar
Description
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
CNVVY Financial Timeline
Browse a chronological timeline of ConvaTec Group Plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 24 Feb 2026
Earnings released on 29 Jul 2025
EPS came in at $0.32 surpassing the estimated $0.31 by +1.72%, while revenue for the quarter reached $1.18B , beating expectations by +0.72%.
Dividend declared on 29 Jul 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend will be paid on 16 Oct 2025.
Earnings released on 16 May 2025
Earnings released on 26 Feb 2025
EPS came in at $0.34 surpassing the estimated $0.32 by +5.50%, while revenue for the quarter reached $1.18B , missing expectations by -0.61%.
Dividend declared on 26 Feb 2025
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 12 Jun 2025.
Dividend declared on 23 Aug 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 21 Oct 2024.
Earnings released on 30 Jul 2024
EPS came in at $0.02 falling short of the estimated $0.28 by -93.11%, while revenue for the quarter reached $556.70M , missing expectations by -49.75%.
Earnings released on 30 Apr 2024
EPS came in at $0.02 , while revenue for the quarter reached $556.70M .
Dividend declared on 25 Apr 2024
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 7 Jun 2024.
Earnings released on 19 Mar 2024
EPS came in at $0.14 , while revenue for the quarter reached $1.08B .
Earnings released on 6 Mar 2024
EPS came in at $0.02 falling short of the estimated $0.24 by -92.44%, while revenue for the quarter reached $543.45M , missing expectations by -50.45%.
Dividend declared on 3 Aug 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 13 Oct 2023.
Earnings released on 29 Jun 2023
EPS came in at $0.11 , while revenue for the quarter reached $1.06B .
Dividend declared on 1 Apr 2023
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 9 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.23 by -94.17%, while revenue for the quarter reached $527.75M , missing expectations by -48.81%.
Earnings released on 30 Dec 2022
EPS came in at $0.03 , while revenue for the quarter reached $1.08B .
Earnings released on 30 Sept 2022
EPS came in at $0.00 falling short of the estimated $0.24 by -98.50%, while revenue for the quarter reached $514.00M , missing expectations by -50.00%.
Dividend declared on 20 Aug 2022
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 21 Oct 2022.
Earnings released on 29 Jun 2022
EPS came in at $0.10 , while revenue for the quarter reached $1.04B .
Earnings released on 31 Mar 2022
EPS came in at $0.01 falling short of the estimated $0.24 by -95.05%, while revenue for the quarter reached $522.25M , missing expectations by -48.86%.
Dividend declared on 31 Mar 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 3 Jun 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.06 , while revenue for the quarter reached $1.04B .
Earnings released on 30 Sept 2021
EPS came in at $0.01 falling short of the estimated $0.24 by -96.73%, while revenue for the quarter reached $515.15M , missing expectations by -49.65%.
Dividend declared on 31 Aug 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 28 Oct 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.17 , while revenue for the quarter reached $1.01B .
Earnings released on 31 Mar 2021
EPS came in at $0.02 falling short of the estimated $0.24 by -91.17%, while revenue for the quarter reached $504.00M , missing expectations by -49.37%.
Dividend declared on 31 Mar 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 27 May 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.10 , while revenue for the quarter reached $968.63M .
Earnings released on 30 Sept 2020
EPS came in at $0.01 falling short of the estimated $0.24 by -94.48%, while revenue for the quarter reached $493.15M , missing expectations by -49.46%.
Dividend declared on 3 Sept 2020
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 29 Oct 2020.
CNVVY Stock Performance
Access detailed CNVVY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.